Predictive Role of Peripheral Blood Lymphocyte And Cytokine Phenotypes in Patients with Operable Breast Cancer And Neoadjuvant Therapy: A Preliminary Study
J Wu, X Ou, K Yuan, F Shi, Q Zhou, S Lyu, Y Li, Y Zhao… - 2024 - researchsquare.com
Background PD-L1 is an indicator for immunotherapy however, the detection is based on
biopsy and affected by tumor heterogeneity and patients' intolerance. This study aimed to …
biopsy and affected by tumor heterogeneity and patients' intolerance. This study aimed to …